Vol. 36 No. 1 (2019): February
Short Communication

Neutropenia associated with the use of cefepime in pediatric patients with cystic fibrosis

Rubén Hernández
Hospital Clínico San Borja Arriarán
Luis Delpiano
Hospital Clínico San Borja Arriarán
Jorge Amador
Hospital Clínico San Borja Arriarán
Mariana Arias
Clínica Las Condes
Juan Carrasco Delgado
Hospital Clínico San Borja Arriarán

Published 2019-04-05

How to Cite

1.
Hernández R, Delpiano L, Amador J, Arias M, Carrasco Delgado J. Neutropenia associated with the use of cefepime in pediatric patients with cystic fibrosis. Rev. Chilena. Infectol. [Internet]. 2019 Apr. 5 [cited 2025 Nov. 26];36(1). Available from: https://revinf.cl/index.php/revinf/article/view/393

Abstract

Pulmonary exacerbations of infectious cause are one of the major complications in patients with cystic fibrosis (CF). These are associated with a progressive increase in morbidity and mortality. The treatment depending on the isolated microorganism. The β-lactam antibiotics are generally used which are not exempt from adverse reactions. Next, two report of neutropenia cases are described after prolonged use of cefepime in CF patients.